Cytotoxic activity |
Cleistantoxin |
Activity was checked against MCF-7, MCF-7R, KBand HT29 cancer cell lines |
Cleistantoxin showed strong cytotoxic activity |
[146] |
Antibacterial activity |
New precursors of podophyllotoxin were synthesized, and screened to check their antibacterial activity |
Activity was checked against Klebsiella pneumoniae, Streptococcus faecalis, Citrobacter sp., Pseudomonas aeruginosa, Escherchia coli, Salmonella typhi and Shigella sonnei
|
Ethyl-2-(3′-methyl-4′-methoxybenzoyl)-3-(4″ methoxyphenol)-cyclopropane-1-carboxylic acid and Ethyl-2-(3′-methyl-4′-methoxybenzyol-3-1 3″, 4″-dimethoxyphenyl)-cyclopropane-carboxylic acid, both of them showed significant antibacterial activity |
[147] |
Antitumour activity |
VP 16-213 (NSC-141540) |
Activity was checked against L1210 ascites tumour in N/D mice |
In 24 hours, divided treatment after every 3 hours, resulted in significant cure, hence, VP 16-213 is a cell cycle specific drug |
[148] |
Insecticidal activity |
20 podophyllotoxin analogues were tested |
Activity was checked against fifth-instar larvae of Brontispa longissima in vivo |
Among 20 analogues Deoxypodophyllotoxin showed more protential for insecticidal activity than a commercial insecticide (toosendanin) |
[149] |
Antineoplastic activity |
New hybrids of podophyllotoxin and indirubin |
Activity was checked against human leukemia cancer cells as a multifunctional anti-MDR agent |
Podophyllotoxin-indirubin hybrid (Da-1) showed potential to overcome drug resistance. It is a novel hybrid havingpotent antiproliferative activity |
[150] |
Cyclolignans, derived from podophyllotoxin |
Activity was checked againstA-549 human lung carcinoma, P-388 murine leukemia and HT-29 colon carcinoma |
A number of substances were active in assay at concentrations below 1 pM; deoxypodophyllotoxin being the most potent compound in all cases |
[151] |